-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Panacea Life Sciences Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q1 2024.
- Panacea Life Sciences Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 16.5M shares, a 10.2% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 16.6M shares, a 11.9% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)